New coronavirus antibody treatment by Eli-Lilly reduces need for hospitalization: study
Treatment reduced hospitalization risk by 72%, said CEO David Ricks
A clinical trial assessing Eli Lilly’s experimental antibody treatment reduced the rate of hospitalization in COVID-19 patients, the pharmaceutical company's CEO David Ricks told FOX Business' Maria Bartiromo on Wednesday.
“This is an important day in the fight against COVID,” Ricks said on “Mornings with Maria.”-- More...
Read next: Bombshell Study Was Covered Up After Confirming Unvaccinated Children Are Healthier
Email Us | Reader Friendly | Comments
Fox News——Bio and Archives
Breaking News, Latest News and Current News from Fox News. Breaking news and video. Latest Current News: U.S.,
